Cargando…
Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213966/ https://www.ncbi.nlm.nih.gov/pubmed/37252152 http://dx.doi.org/10.3389/fpsyt.2023.1164471 |
| _version_ | 1785047740534751232 |
|---|---|
| author | Henssler, Jonathan Bschor, Tom Baethge, Christopher |
| author_facet | Henssler, Jonathan Bschor, Tom Baethge, Christopher |
| author_sort | Henssler, Jonathan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10213966 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102139662023-05-27 Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression Henssler, Jonathan Bschor, Tom Baethge, Christopher Front Psychiatry Psychiatry Frontiers Media S.A. 2023-05-11 /pmc/articles/PMC10213966/ /pubmed/37252152 http://dx.doi.org/10.3389/fpsyt.2023.1164471 Text en Copyright © 2023 Henssler, Bschor and Baethge. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Psychiatry Henssler, Jonathan Bschor, Tom Baethge, Christopher Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| title | Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| title_full | Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| title_fullStr | Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| title_full_unstemmed | Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| title_short | Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| title_sort | commentary: meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression |
| topic | Psychiatry |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213966/ https://www.ncbi.nlm.nih.gov/pubmed/37252152 http://dx.doi.org/10.3389/fpsyt.2023.1164471 |
| work_keys_str_mv | AT hensslerjonathan commentarymetaanalysisoverstatesbenefitofantidepressantcombinationtherapywitha2antagonistsandreuptakeinhibitorsinmajordepression AT bschortom commentarymetaanalysisoverstatesbenefitofantidepressantcombinationtherapywitha2antagonistsandreuptakeinhibitorsinmajordepression AT baethgechristopher commentarymetaanalysisoverstatesbenefitofantidepressantcombinationtherapywitha2antagonistsandreuptakeinhibitorsinmajordepression |